<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A patient with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> who had previously undergone a Cabrol procedure and thoracoabdominal aortic replacement had enlarging, symptomatic <z:hpo ids='HP_0002617'>aneurysms</z:hpo> in the subclavian-axillary artery and aortic arch </plain></SENT>
<SENT sid="1" pm="."><plain>Both vessels were replaced with prosthetic grafts </plain></SENT>
<SENT sid="2" pm="."><plain>A thoracic endoprosthesis was inserted bridging the aortic arch graft and the previously implanted descending aorta graft </plain></SENT>
<SENT sid="3" pm="."><plain>Another stent graft was placed, bridging the axillary artery and a branch of the aortic arch graft </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the stent graft landing zones were within grafts, avoiding contact between the endoprostheses and fragile aortic wall </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:hpo ids='HP_0002617'>aneurysms</z:hpo> were excluded from the circulation, and the patient had no serious complications </plain></SENT>
</text></document>